Muvon Therapeutics has linked its cell therapy to a 60% drop in stress incontinence episode frequency in a small phase 2 ...
Anti-obesity drugs have quickly become popular for aesthetic weight loss in South Korea. Read more at straitstimes.com. Read ...
The final match of the previous game week wrapped up less than 48 hours ago, and we’re already heading straight into Gameweek ...
The Rule 5 Draft is a mechanism that protects against talent hoarding. Teams have only so many years after signing a player before they have to add them to the 40-player roster. Eligible players who ...
Among older patients with newly diagnosed diffuse large B-cell lymphoma (DLBCL), treatment with fixed-duration Epkinly (epcoritamab-bysp) plus dose-attenuated Rituxan (rituximab) plus cyclophosphamide ...
Inquirer on MSN
Thinness obsession prompts diet drug misuse in Korea
A wave of demand for weight-loss medication is sweeping South Korea, a country that remains one of the OECD’s leanest, as ...
A staple in quality strength routines, the overhead press is a compound upper-body move that delivers big bang for your buck ...
One of Hull City's biggest dressing room characters has opened up on his ongoing injury concern, with surgery on the cards ...
Wave Life Sciences Ltd. ( WVE) Discusses Positive Interim Data from INLIGHT Trial of WVE-007 for Obesity December 8, 2025 8:30 AM EST ...
Jennifer Lopez showed off her toned abs ahead of her Vegas show inspiring many women to strengthen their core Fitness expert ...
Poster highlights 6-month follow-up data from the ongoing Phase 2 trial of NDV-01 in non-muscle invasive bladder cancer (NMIBC), with favorable ...
New two- and three-year EPCORE® NHL-2 follow-up data evaluating epcoritamab in combination with standard of care regimens demonstrate remission in patients with DLBCL and FLLatest EPCORE DLBCL-3 trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback